Reduced dopaminergic tone in hypothalamic neural circuits: expression of a "thrifty" genotype underlying the metabolic syndrome?

被引:74
作者
Pijl, H [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Internal Med, NL-2300 RC Leiden, Netherlands
关键词
dopamine; dopamine D2 receptor; metabolic syndrome X; insulin resistance; obesity;
D O I
10.1016/j.ejphar.2003.08.100
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The thrifty genotype hypothesis postulates that the genetically determined ability to grow obese and insulin resistant in times of food abundance confers a survival advantage in times of famine. Obviously, this ability poses a major health threat in modem times, where food is always available in large quantities. In the last 10-15 years, many genes encoding. pathways that orchestrate energy balance and fuel flux have been discovered. This paper summarizes the evidence that diminished dopaminergic tone in hypothalamic nuclei contributes to the "thrifty" genotype/phenotype. Reduced dopaminergic neurotransmission in the suprachiasmatic nucleus of seasonally obese animals appears to drive noradrenalin and NPY mediated transmissions in other nuclei to induce the obesity syndrome at the appropriate time of year. Treatment with dopamine D-2 receptor agonists can fully reverse the metabolic syndrome in these animals. Similar mechanisms are operative in non-seasonal obese animal models. In man, treatment with dopamine D-2 receptor antagonists induces obesity and type 2 diabetes mellitus, whereas dopamine D-2 receptor activation ameliorates the metabolic profile in obese nondiabetic and diabetic humans. Various loss of function mutations of the dopamine D-2 receptor gene are associated with overweight in humans. In concert, the data support the notion that diminution of dopaminergic (dopamine D-2 receptor mediated) transmission in relevant hypothalamic nuclei sets the stage for efficient partitioning of ingested nutrients to contribute to a phenotype that is not so thrifty anymore. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:125 / 131
页数:7
相关论文
共 80 条
[1]   Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence [J].
Arnt, J ;
Skarsfeldt, T .
NEUROPSYCHOPHARMACOLOGY, 1998, 18 (02) :63-101
[2]   Olanzapine-induced glucose dysregulation [J].
Bettinger, TL ;
Mendelson, SC ;
Dorson, PG ;
Crismon, ML .
ANNALS OF PHARMACOTHERAPY, 2000, 34 (7-8) :865-867
[3]   Dopaminergic agonists normalize elevated hypothalamic neuropeptide Y and corticotropin-releasing hormone, body weight gain, and hyperglycemia in ob/ob mice [J].
Bina, KG ;
Cincotta, AH .
NEUROENDOCRINOLOGY, 2000, 71 (01) :68-78
[4]   Increased prevalence of the Taq I A(1) allele of the dopamine receptor gene (DRD(2)) in obesity with comorbid substance use disorder: A preliminary report [J].
Blum, K ;
Braverman, ER ;
Wood, RC ;
Gill, J ;
Li, C ;
Chen, TJH ;
Taub, M ;
Montgomery, AR ;
Sheridan, PJ ;
Cull, JG .
PHARMACOGENETICS, 1996, 6 (04) :297-305
[5]   SUPPRESSION OF BASAL AND STIMULATED NORADRENERGIC ACTIVITIES BY THE DOPAMINE AGONIST BROMOCRIPTINE IN MAN [J].
CAREY, RM ;
VANLOON, GR ;
BAINES, AD ;
KAISER, DL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1983, 56 (03) :595-602
[6]   BROMOCRIPTINE INHIBITS IN-VIVO FREE FATTY-ACID OXIDATION AND HEPATIC GLUCOSE OUTPUT IN SEASONALLY OBESE HAMSTERS (MESOCRICETUS-AURATUS) [J].
CINCOTTA, AH ;
MEIER, AH .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1995, 44 (10) :1349-1355
[7]   Chronic infusion of norepinephrine into the VMH of normal rats induces the obese glucose-intolerant state [J].
Cincotta, AH ;
Luo, SQ ;
Zhang, Y ;
Liang, Y ;
Bina, KG ;
Jetton, TL ;
Scislowski, PWD .
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY, 2000, 278 (02) :R435-R444
[8]   BROMOCRIPTINE REDIRECTS METABOLISM AND PREVENTS SEASONAL ONSET OF OBESE HYPERINSULINEMIC STATE IN SYRIAN-HAMSTERS [J].
CINCOTTA, AH ;
MACEACHERN, TA ;
MEIER, AH .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (02) :E285-E293
[9]   REDUCTIONS OF BODY-FAT STORES AND TOTAL PLASMA-CHOLESTEROL AND TRIGLYCERIDE CONCENTRATIONS IN SEVERAL SPECIES BY BROMOCRIPTINE TREATMENT [J].
CINCOTTA, AH ;
MEIER, AH .
LIFE SCIENCES, 1989, 45 (23) :2247-2254
[10]   Bromocriptine/SKF38393 treatment ameliorates obesity and associated metabolic dysfunctions in obese (ob/ob) mice. [J].
Cincotta, AH ;
Tozzo, E ;
Scislowski, PWD .
LIFE SCIENCES, 1997, 61 (10) :951-956